AI Article Synopsis
- The use of albumin has sparked ongoing debate since the 1940s due to its high cost and potential risks if used improperly.
- In August 1998, a multidisciplinary team established straightforward guidelines for albumin's use, leading to a nearly 70% reduction in its prescriptions.
- This suggests that effective guidelines can promote the responsible use of medical treatments like albumin, rather than relying solely on strict administrative controls.
Article Abstract
The use of albumin has been a matter of debate since its introduction in the 1940's. Albumin is not only expensive but may also be harmful when administered inappropriately. Until recently our use of albumin was controlled by a number of authorized physicians who signed all albumin prescriptions. In August 1998, a multidisciplinary team reviewed the indications for albumin use and introduced simple guidelines for its supply and administration. As a result, the use of albumin has decreased by almost 70%. This indicates that rational use of albumin can be achieved by appropriate guidelines, without requiring administrative limitations. We believe that this conclusion holds true for other diagnostic and therapeutic procedures as well.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!